Growing community of inventors

Jiangsu, China

Lizhen Wu

Average Co-Inventor Count = 12.17

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Lizhen WuYe Edward Tian (5 patents)Lizhen WuLijun Liu (5 patents)Lizhen WuXiaozhu Wang (4 patents)Lizhen WuFeng Yin (4 patents)Lizhen WuHaijun Dong (4 patents)Lizhen WuGuoxiang Wang (4 patents)Lizhen WuQingbing Xu (4 patents)Lizhen WuYangzhen Jiang (4 patents)Lizhen WuSui Xiong Cai (3 patents)Lizhen WuChengyun Gu (3 patents)Lizhen WuXiuhua Hu (3 patents)Lizhen WuSishun Kang (3 patents)Lizhen WuShengzhi Chen (3 patents)Lizhen WuQingli Bao (3 patents)Lizhen WuSuixiong Cai (2 patents)Lizhen WuSheng Bi (1 patent)Lizhen WuLei Chen (1 patent)Lizhen WuZheng Meng (1 patent)Lizhen WuXiuyan Zhang (1 patent)Lizhen WuZenghui Yu (1 patent)Lizhen WuXiaozhu Wang (1 patent)Lizhen WuGuoxiang Wang (1 patent)Lizhen WuLijun Liu (1 patent)Lizhen WuLizhen Wu (5 patents)Ye Edward TianYe Edward Tian (14 patents)Lijun LiuLijun Liu (5 patents)Xiaozhu WangXiaozhu Wang (8 patents)Feng YinFeng Yin (5 patents)Haijun DongHaijun Dong (5 patents)Guoxiang WangGuoxiang Wang (4 patents)Qingbing XuQingbing Xu (4 patents)Yangzhen JiangYangzhen Jiang (4 patents)Sui Xiong CaiSui Xiong Cai (8 patents)Chengyun GuChengyun Gu (4 patents)Xiuhua HuXiuhua Hu (4 patents)Sishun KangSishun Kang (4 patents)Shengzhi ChenShengzhi Chen (4 patents)Qingli BaoQingli Bao (3 patents)Suixiong CaiSuixiong Cai (8 patents)Sheng BiSheng Bi (3 patents)Lei ChenLei Chen (3 patents)Zheng MengZheng Meng (2 patents)Xiuyan ZhangXiuyan Zhang (2 patents)Zenghui YuZenghui Yu (1 patent)Xiaozhu WangXiaozhu Wang (1 patent)Guoxiang WangGuoxiang Wang (1 patent)Lijun LiuLijun Liu (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Impact Therapeutics, Inc. (4 from 11 patents)

2. Other (1 from 832,843 patents)


5 patents:

1. 11358955 - 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

2. 10316027 - 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

3. 9926304 - 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

4. 9199983 - 3-aryl-6-aryl-[1,2,4]triazolo[4,3-α]pyridines as inhibitors of cell proliferation and the use thereof

5. 9102631 - 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…